KMC Speciality Hospitals (India) Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 investor presentation: what the company reported on revenue, margins and capex.
Top 10 Healthcare Services companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on KMC Speciality Hospitals (India) Ltd's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) - Q4 FY’26 Total Income: INR 84.2 Cr, up 36% YoY from INR 61.7 Cr in Q4 FY’25 (Pages 14, 15) - Q4 FY’26 In-Patient Volumes: 4,823, up 17% YoY from 4,137 in Q4 FY’25 (Page 16) - Q4 FY’26 Out-Patient Volumes: 55,630, up 32% YoY from 42,034 in Q4 FY’25 (Page 16) - Q4 FY’26 Occupied Beds approx. Q4 FY'26 EBITDA: INR 27.8 Cr, up 71% year-on-year from INR 16.2 Cr in Q4 FY'25.
From KMC Speciality Hospitals (India) Ltd's Q4 FY26 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20)
- Q4 FY’26 Total Income: INR 84.2 Cr, up 36% YoY from INR 61.7 Cr in Q4 FY’25 (Pages 14, 15)
- Q4 FY’26 In-Patient Volumes: 4,823, up 17% YoY from 4,137 in Q4 FY’25 (Page 16)
- Q4 FY’26 Out-Patient Volumes: 55,630, up 32% YoY from 42,034 in Q4 FY’25 (Page 16)
2 more points from KMC Speciality Hospitals (India) Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what KMC Speciality Hospitals (India) Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- New facility "Maa Kauvery" with 200 beds announced and operational from January 2024 (Page 8, 32).
- Loan availed for "Maa Kauvery" facility reflected in financials from FY’24; total borrowings for new facility INR 71.03 Cr as of FY’26 (Pages 29, 31, 21).
- Capacity expansion from 205 beds to 330 beds by FY’25; census beds increased to 330 by FY’25 and maintained in FY’26 (Pages 33, 24).
2 more points from KMC Speciality Hospitals (India) Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what KMC Speciality Hospitals (India) Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what KMC Speciality Hospitals (India) Ltd said on order book & pipeline — free account, 30 seconds.
KMC Speciality Hospitals (India) Ltd — Quarterly revenue & net profit
Q4 FY26 figures are not in this chart yet. Latest shown: Dec 2025 (Q3 FY26). The Q4 FY26 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q3 FY26): revenue ₹82 Cr, net profit ₹14 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What KMC Speciality's management said in earlier quarters
Others in Healthcare Services this season
- Suven Life Sciences (Q4 FY26)
The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su
- Invicta Diagnostic (Q4 FY26)
Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnostic's Q4 FY26 earnings…
- Star Imaging (Q4 FY26)
Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…
- Gaudium IVF (Q4 FY26)
Revenue growth seen in FY26: INR 104.35 crore, a 47.56% increase from FY25. Key concall takeaways from Gaudium IVF's Q4 FY26 earnings call — and how it ranks…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
KMC Speciality Hospitals (India) Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were KMC Speciality Hospitals (India) Ltd Q4 FY26 results?
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) - Q4 FY’26 Total Income: INR 84.2 Cr, up 36% YoY from INR 61.7 Cr in Q4 FY’25 (Pages 14, 15) - Q4 FY’26 In-Patient Volumes: 4,823, up 17% YoY from 4,137 in Q4 FY’25 (Page 16) - Q4 FY’26 Out-Patient Volumes: 55,630, up 32% YoY from 42,034 in Q4 FY’25 (Page 16) - Q4 FY’26 Occupied Beds approx. Q4 FY'26 EBITDA: INR 27.8 Cr, up 71% year-on-year from INR 16.2 Cr in Q4 FY'25.
What is KMC Speciality Hospitals (India) Ltd share price analysis?
KMC Speciality Hospitals (India) Ltd currently shows a neutral. The stock trades at a P/E of 43.9 with a market cap of ₹2,451 Cr. Investors should review the full earnings analysis for detailed insights.
Is KMC Speciality Hospitals (India) Ltd planning capital expenditure?
New facility "Maa Kauvery" with 200 beds announced and operational from January 2024 (Page 8, 32).
Keep KMC Speciality Hospitals (India) Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
